BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carrico AW, Cherenack EM, Roach ME, Riley ED, Oni O, Dilworth SE, Shoptaw S, Hunt P, Roy S, Pallikkuth S, Pahwa S. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 2018;32:767-71. [PMID: 29369159 DOI: 10.1097/QAD.0000000000001751] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li MJ, Richter EI, Okafor CN, Kalmin MM, Dalvie S, Takada S, Gorbach PM, Shoptaw SJ, Cole SW. Social Genomics of Methamphetamine Use, HIV Viral Load, and Social Adversity. Annals of Behavioral Medicine 2022;56:900-908. [DOI: 10.1093/abm/kaab096] [Reference Citation Analysis]
2 Riley ED, Kizer JR, Tien PC, Vittinghoff E, Lynch KL, Wu AHB, Coffin PO, Beck-Engeser G, Braun C, Hunt PW. Multiple substance use, inflammation and cardiac stretch in women living with HIV. Drug Alcohol Depend 2022;238:109564. [PMID: 35872529 DOI: 10.1016/j.drugalcdep.2022.109564] [Reference Citation Analysis]
3 Yin L, Dinasarapu AR, Borkar SA, Chang KF, De Paris K, Kim-Chang JJ, Sleasman JW, Goodenow MM. Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana. Retrovirology 2022;19:10. [PMID: 35642061 DOI: 10.1186/s12977-022-00594-4] [Reference Citation Analysis]
4 Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Curr HIV/AIDS Rep 2021;18:538-48. [PMID: 34843065 DOI: 10.1007/s11904-021-00582-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fattakhov N, Torices S, Stangis M, Park M, Toborek M. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders. Viruses 2021;13:1883. [PMID: 34578464 DOI: 10.3390/v13091883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Assis MA, Carranza PG, Ambrosio E. A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV. Viruses 2021;13:722. [PMID: 33919273 DOI: 10.3390/v13050722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rivera AV, Harriman G, Carrillo SA, Braunstein SL. Trends in Methamphetamine Use Among Men Who Have Sex with Men in New York City, 2004-2017. AIDS Behav 2021;25:1210-8. [PMID: 33185774 DOI: 10.1007/s10461-020-03097-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
8 Mehta SR, Iudicello JE, Lin J, Ellis RJ, Morgan E, Okwuegbuna O, Cookson D, Karris M, Saloner R, Heaton R, Grant I, Letendre S; TMARC Group. Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk. Drug Alcohol Depend 2021;221:108639. [PMID: 33621803 DOI: 10.1016/j.drugalcdep.2021.108639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Feelemyer J, Arasteh K, Huong DT, Oanh KTH, Khue PM, Giang HT, Thanh NTT, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Nagot N, Des Jarlais DC; DRIVE STUDY TEAM. Associations between methamphetamine use and lack of viral suppression among a cohort of HIV-positive persons who inject drugs in Hai Phong, Vietnam. AIDS 2020;34:1875-82. [PMID: 32910061 DOI: 10.1097/QAD.0000000000002680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S, Pallikkuth S, Hirshfield S. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS Behav 2020;24:3020-3. [PMID: 32266501 DOI: 10.1007/s10461-020-02854-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
11 Azzoni L, Metzger D, Montaner LJ. Effect of Opioid Use on Immune Activation and HIV Persistence on ART. J Neuroimmune Pharmacol 2020;15:643-57. [PMID: 32974750 DOI: 10.1007/s11481-020-09959-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee J, Lee JY, Meade CS, Cohn M, Chahine A, Dilworth SE, Magidson JF, Gouse H, Fuchs D, Carrico AW. Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection. J Neurovirol 2020;26:779-84. [PMID: 32728896 DOI: 10.1007/s13365-020-00841-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Vidot DC, Manuzak JA, Klatt NR, Pallikkuth S, Roach M, Dilworth SE, Pahwa S, Carrico AW. Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection. J Acquir Immune Defic Syndr 2019;81:361-4. [PMID: 30958388 DOI: 10.1097/QAI.0000000000002046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Oni O, Glynn TR, Antoni MH, Jemison D, Rodriguez A, Sharkey M, Salinas J, Stevenson M, Carrico AW. Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence. Int J Behav Med 2019;26:542-50. [PMID: 31313251 DOI: 10.1007/s12529-019-09804-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Costiniuk CT, Jenabian MA. Cannabinoids and inflammation: implications for people living with HIV. AIDS 2019;33:2273-88. [PMID: 31764093 DOI: 10.1097/QAD.0000000000002345] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
16 Castro FOF, Silva JM, Dorneles GP, Barros JBS, Ribeiro CB, Noronha I, Barbosa GR, Souza LCS, Guilarde AO, Pereira AJCS, Guimarães RF, Oliveira TF, Oliveira SEF, Peres A, Romão PRT, Pfrimer IAH, Fonseca SGD. Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine. AIDS 2019;33:1831-42. [PMID: 31490211 DOI: 10.1097/QAD.0000000000002296] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
17 Chilunda V, Calderon TM, Martinez-Aguado P, Berman JW. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Brain Res 2019;1724:146426. [PMID: 31473221 DOI: 10.1016/j.brainres.2019.146426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
18 Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, Shoptaw S, Flowers E, Dilworth SE, Pahwa S, Aouizerat BE. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 2018;71:108-15. [PMID: 29679637 DOI: 10.1016/j.bbi.2018.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
19 Dennin RH, Sinn A, Du Z. The Disregarded HIV Prevention Strategies—Their Potential to Uphold the Pandemic, and the Challenges Facing Societies. WJA 2018;08:137-159. [DOI: 10.4236/wja.2018.84011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]